RGEN Repligen Corporation

33.12
-0.14  -0%
Previous Close 33.26
Open 33.58
Price To book 2.50
Market Cap 1442882935
Shares 43,565,306
Volume 41,622
Short Ratio 8.60
Av. Daily Volume 501,644

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL received June 22, 2012.
RG1068
Detection of pancreatic duct abnormalities

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171190175
  2. 8-K - Current report 171188322
  3. 8-K/A [Amend] - Current report 171133785
  4. SC 13G - Statement of acquisition of beneficial ownership by individuals 171041955
  5. D - Notice of Exempt Offering of Securities 171015238
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 171004975
  7. 8-K - Current report 171002845
  8. 8-K - Current report 171002844
  9. 8-K - Current report 17936705
  10. 424B5 - Prospectus [Rule 424(b)(5)] 17936690